ABSTRACT
The clinical benefit offered by novel drug delivery systems over traditional routes of delivery for existing drugs is often outweighed by their associated increased costs. The rationale for developing novel drug delivery systems therefore lies primarily in the potential commercial benefits of developing more effective means of delivering the new biotherapeutic agents. This chapter gives a market perspective to the rationale for the development of novel drug delivery systems.
